Akin represented Angelo Gordon on the deal. Angelo Gordon, a $73 billion* alternative investment firm focused on credit and real estate investing, announced the fundraising of AG...
Angelo Gordon’s $1 Billion Fundraise of AG Asset-Based Credit Fund
Paine Schwartz Partners’ Investment in Elemental Enzymes
Akin advised Paine Schwartz Partners on the deal. Paine Schwartz Partners, a global leader in sustainable food chain investing, announced that it has completed a strategic...
Pharmakon Advisors’ $450 Million Commitment to BioCryst Pharmaceuticals
Akin advised Pharmakon Advisors on the deal. Pharmakon Advisors, LP, a leading investor in non-dilutive debt for the life sciences industry, announced its $450 million financing commitment...
Pharmakon’s Loan Agreement with Immunocore
Fenwick advised Pharmakon on the deal while Akin Gump advised Pharmakon Advisors. Pharmakon, an investor in non-dilutive debt for the life sciences industry and the investment...
ProKidney’s Combination With Social Capital Suvretta Holdings Corp. III
Wachtell, Lipton, Rosen & Katz acted as legal advisor to SCS. Davis Polk & Wardwell and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C, Matheson, Akin...
Crayhill Capital Management’s $820 Million Fund Closing
Akin Gump Strauss Hauer & Feld advised Crayhill Capital Management on the deal. Crayhill Capital Management announced the final close of Crayhill Principal Strategies Fund II with...